Throughout September, the FDA approved drugs for the treatment of diseases including lung cancer, multiple myeloma, thyroid ...

In less than a month, from August 20 to September 19, amivantamab (Ami; Rybrevant, Johnson & Johnson) received 2 approvals ...

Panelists discuss how HER2-directed therapies in non–small cell lung cancer (NSCLC) are evolving, with experts examining the distinction between HER2 mutation and expression, evaluating the efficacy ...

Kiromic BioPharma, Inc. (OTCQB: KRBP) ("Kiromic" or the "Company") reports good safety and favorable ongoing efficacy results from the 10-month follow-up visit of the first patient treated in its ...

Immune checkpoint inhibitors industry is projected to witness a CAGR of 16.7% during the period 2024-2032. This growth can be ...

Non-small cell lung cancer (NSCLC) is a type of cancer that begins in the tissues of the lungs, the two spongy organs in your chest that help your body absorb oxygen. Lung cancer is the third most ...

AstraZeneca and Daiichi Sankyo announced that their drug Enhertu (trastuzumab deruxtecan) has been granted Priority Review by the US FDA for trea ...

Hatim Husain, MD, discusses how acquired resistance to kinase inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC) poses a significant challenge in long-term treatment efficacy, necessitating ...

Despite recent advances in the treatment of breast cancer, it remains the second leading cause of cancer death in the U.S.

About 25 people were feared dead in Thailand on Tuesday when a school bus carrying students and teachers on a field trip caught fire on the outskirts of the capital Bangkok, with 16 passengers ...

Hezbollah claimed Israel had carried out the strikes in Kola on their Telegram channel. Information ...

'Trust has become biggest casualty': What Army chief said on LAC standoff with China Army Chief Upendra Dwivedi stated that the situation along the LAC in eastern Ladakh is stable but sensitive ...